Familial nephropathy and multiple exostoses with Exostosin-1 (EXT1) gene mutation

Journal of the American Society of Nephrology

Volumn 19, Issue 3, 2008, Pages 450-453

  Roberts, Ian S D ^a   Gleadle, Jonathan M ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLYCOSYLTRANSFERASE; HEPARAN SULFATE; PERLECAN; PREDNISOLONE;

ADULT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; FAMILIAL NEPHROPATHY; FEMALE; GENE MUTATION; GENE SEQUENCE; GLOMERULOPATHY; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; NAIL PATELLA SYNDROME; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SHORT SURVEY;

EID: 40449139078     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007080842     Document Type: Short Survey

References (19)

1. Vollrath D, Jaramillo-Babb VL, Clough MV, McIntosh I, Scott KM, Lichter PR, Richards JE: Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail patella syndrome Hum Mol Genet 7: 1091-1098, 1998
2. Heidet L, Bongers EMHF, Sich M, Zhang SY, Loirat C, Meyrier A, Broyer M, Landthaler G, Faller B, Sado Y, Knoers NV, Gubier MC: In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am J Pathol 163: 145-155, 2003
3. Bongers EM, Huysmans FT, Levtchenko E, de Rooy JW, Blickman JG, Admiraal RJ, Huygen PL, Cruysberg JR, Toolens PA, Prins JB, Krabbe PF, Borm GF, Schoots J, van Bokhoven H, van Remortele AM, Hoefsloot LH, van Kampen A, Knoers NV: Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy. Eur J Hum Genet 13: 935-946, 2005
4. Alchi B, Nishi S, Narita I, Gejyo F: Collagenofibrotic glomerulopathy: clinicopathologic overview of a rare glomerular disease. Am J Kidney Dis 49: 499-506, 2007
5. Yasuda T, Imai H, Nakamoto Y, Ohtani H, Komatsuda A, Wakui H, Miura AB: Collagenofibrotic glomerulopathy: a systemic disease: Am J Kidney Dis 33:123-127, 1999
6. McCormick C, Duncan G, Goutsos KT, Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulphate. Proc Natl Acad Sci U S A 97: 668-673, 2000
7. Hall CR, Cole WG, Haynes R, Hecht JT: Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Am J Med Genet 112: 1-5, 2002
8. Hecht JT, Hall CR, Snuggs M, Hayes E, Haynes R, Cole WG: Heparan sulphate abnormalities in exostoses growth plates. Bone 31: 199-204, 2002
9. Legeai-Mallet L, Rossi A, Benoist-Lasselin C, Piazza R, Mallet JF, Delezoide AL, Munnich A, Bonaventure J, Zylberberg L: EXT-1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses. J Bone Miner Res 15: 1489-1500, 2000
10. Kanwar YS, Linker A, Farquhar MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 86: 688-693, 1980
11. Daniels BS: Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. J Lab Clin Med 124: 224-230, 1994
12. van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41: 115-123, 1992
13. Levidiotis V, Kanellis J, Ierino FL, Power DA: Increased expression of heparinase in puromycin aminonucleoside nephrosis. Kidney Int 60: 1287-1296, 2001
14. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li J-P, Lindahl U, Vlodavsky I: Transgenic expression of mammalian heparinase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularisation and feeding behaviour. FASEB J 18: 252-263, 2004
15. Branten AJW, van den Born J, Jansen JLJ, Assmann KJM, Wetzels JFM: Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int 59: 693-701, 2001
16. Holt RCL, Webb NJA, Ralph S, Davies J, Short CD, Brenchley PEC: Heparinase activity is dysregulated in children with steroid-sensitive nephrotic syndrome. Kidney Int 67: 122-129, 2005
17. Fuchshuber A, Gribouval O, Ronner V, Kroiss S, Karle S, Brandis M, Hildebrandt F: Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. J Am Soc Nephrol 12: 374-378, 2001
18. Landau D, Oved T, Geiger D, Abizov L, Shalev H, Parvari R: Familial steroid-sensitive nephrotic syndrome in Southern Israel: clinical and genetic observations. Pediatr Nephrol 22: 661-669, 2007
19. Ludecke HJ, Wagner MJ, Nardmann J, La Pillo B, Parrish JE, Willems PJ, Haan EA, Frydman M, Hamers GJ, Weils DE, Horsthemke B: Molecular dissection of a contiguous gene syndrome: localization of the genes involved in the Langer-Giedion syndrome. Hum Mol Genet 4: 31-36, 1995